Jane Henderson Insider Trading
Get free email notifications about insider trading for Jane Henderson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jane Henderson. Jane Henderson is a Chief Financial Officer & CBO in PANACOS PHARMACEUTICALS, INC. ($VITX) and a Chief Financial Officer, CBO in PANACOS PHARMACEUTICALS, INC. ($VITX) and a Director in Ophthotech Corp. ($OPHT) and a Director in Eleven Biotherapeutics, Inc. ($EBIO) and a CFO & SVP, Corp. Dev. in Voyager Therapeutics, Inc. ($VYGR) and a Sr. V.P. & CFO in Voyager Therapeutics, Inc. ($VYGR) and a Sr. V.P. & CFO, Corp. Dev. in Voyager Therapeutics, Inc. ($VYGR) and a Director in Akero Therapeutics, Inc. ($AKRO).
Address: C/O PANACOS PHARMACEUTICALS, INC. 134 COOLIDGE AVENUE WATERTOWN 02048 MA
Companies in which Jane Henderson is an Insider
Akero Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jane Henderson: Director
Holdings: 0 shares
Latest Transaction: Jun 02 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IVERIC bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jane Henderson: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 11 2020
$OPHT Market Capitalization: $156.71M
$OPHT Previous Close: $4.43
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PANACOS PHARMACEUTICALS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jane Henderson: Chief Financial Officer & CBO, Chief Financial Officer, CBO
Holdings: 125,000 shares
Latest Transaction: May 02 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sesen Bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jane Henderson: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 10 2021
$SESN Market Capitalization: $34.48M
$SESN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Voyager Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jane Henderson: Sr. V.P. & CFO, Corp. Dev., CFO & SVP, Corp. Dev., Sr. V.P. & CFO
Holdings: 19,900 shares
Current Value: $234,024
Latest Transaction: Mar 26 2018
$VYGR Market Capitalization: $316.10M
$VYGR Previous Close: $11.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Jane Henderson
Sentiment: All, AKRO, OPHT, VITX, SESN, VYGR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | SESN | Sesen Bio, Inc. | Henderson Jane | Director | Option Exercise | A | 2.79 | 92,500 | 258,075 | 92,500 | |
| Jun 11 2020 | OPHT | IVERIC bio, Inc. | Henderson Jane | Director | Option Exercise | A | 4.14 | 16,000 | 66,240 | 16,000 | |
| Jun 02 2020 | AKRO | Akero Therapeutics ... | Henderson Jane | Director | Option Exercise | A | 25.20 | 13,000 | 327,600 | 13,000 | |
| May 08 2020 | SESN | Sesen Bio, Inc. | Henderson Jane | Director | Option Exercise | A | 0.63 | 59,000 | 37,135 | 59,000 | |
| Jun 21 2019 | SESN | Sesen Bio, Inc. | Henderson Jane | Director | Option Exercise | A | 1.48 | 52,500 | 77,700 | 52,500 | |
| May 16 2019 | OPHT | IVERIC bio, Inc. | Henderson Jane | Director | Option Exercise | A | 1.39 | 16,000 | 22,240 | 16,000 | |
| Jul 11 2018 | OPHT | Ophthotech Corp. | Henderson Jane | Director | Option Exercise | A | 2.78 | 16,000 | 44,400 | 16,000 |